A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome

Karin Boslooper; Peter Joosten; Nic J. G. M. Veeger; Robby Kibbelaar; Eric van Roon; Sjoerd Hovenga; Gerhard Woolthuis; Hanneke C. Kluin-Nelemans; Mels Hoogendoorn

A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome

Karin Boslooper, Peter Joosten, Nic J. G. M. Veeger, Robby Kibbelaar, Eric van Roon, Sjoerd Hovenga, Gerhard Woolthuis, Hanneke C. Kluin-Nelemans, Mels Hoogendoorn

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Number of pages	2
Journal	Blood
Volume	120
Issue number	21
Publication status	Published - 16-Nov-2012
Event	54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - Atlanta, Gabon Duration: 8-Dec-2012 → 11-Dec-2012

Handle.net

Persistent link

Cite this

Boslooper, K., Joosten, P., Veeger, N. J. G. M., Kibbelaar, R., van Roon, E., Hovenga, S., Woolthuis, G., Kluin-Nelemans, H. C., & Hoogendoorn, M. (2012). A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome. Blood, 120(21).

@article{eefaf4efac9f4d9cbbe282b1464007ae,

title = "A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome",

author = "Karin Boslooper and Peter Joosten and Veeger, {Nic J. G. M.} and Robby Kibbelaar and {van Roon}, Eric and Sjoerd Hovenga and Gerhard Woolthuis and Kluin-Nelemans, {Hanneke C.} and Mels Hoogendoorn",

year = "2012",

month = nov,

day = "16",

language = "English",

volume = "120",

journal = "Blood",

issn = "0006-4971",

publisher = "AMER SOC HEMATOLOGY",

number = "21",

note = "54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) ; Conference date: 08-12-2012 Through 11-12-2012",

}

Boslooper, K, Joosten, P, Veeger, NJGM, Kibbelaar, R, van Roon, E, Hovenga, S, Woolthuis, G, Kluin-Nelemans, HC & Hoogendoorn, M 2012, 'A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome', Blood, vol. 120, no. 21.

A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome. / Boslooper, Karin; Joosten, Peter; Veeger, Nic J. G. M. et al.
In: Blood, Vol. 120, No. 21, 16.11.2012.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy

T2 - 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)

AU - Boslooper, Karin

AU - Joosten, Peter

AU - Veeger, Nic J. G. M.

AU - Kibbelaar, Robby

AU - van Roon, Eric

AU - Hovenga, Sjoerd

AU - Woolthuis, Gerhard

AU - Kluin-Nelemans, Hanneke C.

AU - Hoogendoorn, Mels

PY - 2012/11/16

Y1 - 2012/11/16

M3 - Meeting Abstract

SN - 0006-4971

VL - 120

JO - Blood

JF - Blood

IS - 21

Y2 - 8 December 2012 through 11 December 2012

ER -